CA1246568A — Substituted 6-aryl-1,2,4-triazolo[4,3- b]pyridazines - their preparation and their use
Assigned to Hoechst AG · Expires 1988-12-13 · 37y expired
What this patent protects
Abstract of the disclosure New compounds of the general formula I (I) and salts thereof with a physiologically acceptable acid and a process for their preparation are described. The new compounds have an anxiolytic and anti-convulsive action.
USPTO Abstract
Abstract of the disclosure New compounds of the general formula I (I) and salts thereof with a physiologically acceptable acid and a process for their preparation are described. The new compounds have an anxiolytic and anti-convulsive action.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.